Recent Finacing
Recent Raise
SFA Therapeutics is a clinical-stage biotech developing oral SFA-002, a short-chain fatty acid formulation that modulates immunity to treat autoimmune and inflammatory diseases; in Phase 1b with patent protection.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
See the team members at SFA Therapeutics.
